IRWD
NASDAQ · Biotechnology
Ironwood Pharmaceuticals Inc
$4.36
+0.13 (+3.07%)
Open$4.20
Previous Close$4.23
Day High$4.39
Day Low$4.17
52W High$5.78
52W Low$1.26
Volume—
Avg Volume1.53M
Market Cap707.23M
P/E Ratio5.45
EPS$0.76
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+1,085.8% upside
Current
$4.36
$4.36
Target
$51.70
$51.70
$40.79
$51.70 avg
$62.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 294.75M | 328.67M | 73.58M |
| Net Income | 23.91M | 23.99M | 12.49M |
| Profit Margin | 8.1% | 7.7% | 17.0% |
| EBITDA | 99.90M | 105.83M | 23.02M |
| Free Cash Flow | — | — | 13.98M |
| Rev Growth | -10.3% | -10.3% | +11.9% |
| Debt/Equity | 0.61 | 0.61 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |